Skip to main content

Peer Review reports

From: Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review

Original Submission
27 Aug 2020 Submitted Original manuscript
21 Sep 2020 Reviewed Reviewer Report
14 Mar 2021 Reviewed Reviewer Report
31 Mar 2021 Author responded Author comments - Zohreh Maghsoomi
Resubmission - Version 2
31 Mar 2021 Submitted Manuscript version 2
12 Apr 2021 Reviewed Reviewer Report
25 Apr 2021 Author responded Author comments - Zohreh Maghsoomi
Resubmission - Version 3
25 Apr 2021 Submitted Manuscript version 3
Publishing
26 Apr 2021 Editorially accepted
20 May 2021 Article published 10.1186/s12885-021-08257-x

You can find further information about peer review here.

Back to article page